[HTML][HTML] Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker …
JS Richards, TU Arumugam, L Reiling… - The Journal of …, 2013 - journals.aai.org
The development of effective malaria vaccines and immune biomarkers of malaria is a high
priority for malaria control and elimination. Ags expressed by merozoites of Plasmodium …
priority for malaria control and elimination. Ags expressed by merozoites of Plasmodium …
The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas
MPG Jepsen, PS Jogdand, SK Singh… - The Journal of …, 2013 - academic.oup.com
Background. GMZ2 is a hybrid protein consisting of the N-terminal region of the glutamate-
rich protein fused in frame to the C-terminal region of merozoite surface protein 3 (MSP3) …
rich protein fused in frame to the C-terminal region of merozoite surface protein 3 (MSP3) …
Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia
Abstract Background In Ethiopia, the general population is vulnerable to unpredictable
epidemics of Plasmodium falciparum malaria. However, there is little information on the anti …
epidemics of Plasmodium falciparum malaria. However, there is little information on the anti …
Genetic polymorphisms in the glutamate-rich protein of Plasmodium falciparum field isolates from a malaria-endemic area of Brazil
LR Pratt-Riccio, DS Perce-da-Silva… - Memorias do Instituto …, 2013 - SciELO Brasil
The genetic diversity displayed by Plasmodium falciparum, the most deadly Plasmodium
species, is a significant obstacle for effective malaria vaccine development. In this study, we …
species, is a significant obstacle for effective malaria vaccine development. In this study, we …
How Should Antibodies against P. falciparum Merozoite Antigens Be Measured?
S Chuangchaiya, KEM Persson - Journal of Tropical Medicine, 2013 - Wiley Online Library
Immunity against malaria develops slowly and only after repeated exposure to the parasite.
Many of those that die of the disease are children under five years of age. Antibodies are an …
Many of those that die of the disease are children under five years of age. Antibodies are an …
Genetic polymorphisms in the glutamate-rich protein of Plasmodium falciparum field isolates from a malaria-endemic area of Brazil
The genetic diversity displayed by Plasmodium falciparum, the most deadly Plasmodium
species, is a significant obstacle for effective malaria vaccine development. In this study, we …
species, is a significant obstacle for effective malaria vaccine development. In this study, we …
[引用][C] Assessment of the immune responses to malaria vaccine candidates in immunised volunteers and exposed populations
MPG Jepsen